Recursion Pharmaceuticals Stock Drops: What's Behind It?

Recursion Pharmaceuticals Inc RXRX shares are under pressure Wednesday after new regulatory filings showed that Nvidia Corp ...

Recursion Pharmaceuticals, Inc. (RXRX) advances AI drug discovery amid market shifts

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the AI stocks that will go to the moon. On February 18, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) came under pressure after regulatory ...
Blockonomi

Cathie Wood ARK ETF Buys Recursion Pharmaceuticals and CRISPR Therapeutics Shares

Cathie Wood's ARK Invest bought Recursion Pharmaceuticals and CRISPR Therapeutics while selling PagerDuty, Teradyne, and Salesforce on8, 2026.
UC San Diego Today

A New Method to Steer AI Output Uncovers Vulnerabilities and Potential Improvements

A team of researchers has found a way to steer the output of large language models by manipulating specific concepts inside ...